Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

biote Corp. BTMDW OTC

Other OTC • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
78/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

biote Corp. (BTMDW) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.

BTMDW Analyst Ratings

Buy
2
Ratings
2 Buy
Based on 2 analysts giving stock ratings to biote Corp. in the past 3 months
Rating breakdown
Buy
2 100%
100%
Buy
2 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

People Also View

NNAVW
NNAVW
NextNav Inc.
$6.46
+0.47%
 ALVOW
ALVOW
Alvotech
$0.26
-10.34%
 CDAQW
CDAQW
Compass Digital Acquisition Corp.
$0.06
-20.38%
 ADALW
ADALW
Anthemis Digital Acquisitions I Corp
$0.00
-42.12%
 GROV-WT
GROV-WT
Grove Collaborative Holdings, Inc.
$0.01
+0.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message